ID   MED3
AC   CVCL_VU74
DR   Wikidata; Q95988366
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27498314; DOI=10.1016/j.jbiotec.2016.07.028;
RA   Ivanov, Delyan P.
RA   Coyle, Beth
RA   Walker, David A.
RA   Grabowska, Anna M.
RT   "In vitro models of medulloblastoma: choosing the right tool for the
RT   job.";
RL   J. Biotechnol. 236:10-25(2016).
//
RX   PubMed=24887326; DOI=10.1186/2051-5960-2-57; PMCID=PMC4229867;
RA   Othman, Ramadhan T.
RA   Kimishi, Ioanna
RA   Bradshaw, Tracey D.
RA   Storer, Lisa C.D.
RA   Korshunov, Andrey
RA   Pfister, Stefan Michael
RA   Grundy, Richard G.
RA   Kerr, Ian D.
RA   Coyle, Beth
RT   "Overcoming multiple drug resistance mechanisms in medulloblastoma.";
RL   Acta Neuropathol. Commun. 2:57.1-57.14(2014).
//